scispace - formally typeset
X

Xiao-Dong Zhu

Researcher at Fudan University

Publications -  166
Citations -  5158

Xiao-Dong Zhu is an academic researcher from Fudan University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 27, co-authored 129 publications receiving 3734 citations. Previous affiliations of Xiao-Dong Zhu include Fudan University Shanghai Medical College & Chinese Ministry of Education.

Papers
More filters
Journal ArticleDOI

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

TL;DR: High peritumoral M-CSF and M Phi were associated with HCC progression, disease recurrence, and poor survival after hepatectomy, highlighting the importance of peritUMoral tissue in the recurrence and metastasis of HCC.
Journal ArticleDOI

Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects

TL;DR: Although sorafenib significantly inhibited tumor growth and lung metastasis, it induced a significant increase in peripheral recruitment and intratumoral infiltration of F4/80- and CD11b-positive cells, which was accompanied with elevation of colony-stimulating factor-1, stromal-derived factor 1α, and vascular endothelial growth factor in the tumor and peripheral blood, suggesting the role of macrophages in tumor progression under sorAFenib treatment.
Journal ArticleDOI

Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.

TL;DR: TECs possessed enhanced angiogenic activity and resistance to chemotherapeutic drugs and an angiogenesis inhibitor, and may provide a better tool for studying tumorAngiogenesis and antiangiogenesis drugs in HCC.